-
Because of the flu vaccine shortage, it is even more important this year to emphasize with patients the basic of good health habits that can help prevent the spread of flu.
-
Two new studies suggest intradermal delivery of a reduced dose could expand the supply of influenza vaccine. This approach may be a promising way to address critical shortages of the flu vaccine, such as those experienced across the country this year. At least one physician, however, doesnt agree.
-
FDA moves to strengthen drug safety program; Pfizer to sponsor new celecoxib clinical trial; New drug safety warnings issued.
-
Lanthanum carbonate (Fosrenol) by Shire Pharmaceuticals Group, New indication for infliximab (Remicade) by Centocor, New indication for letrozole tablets (Femara) by Novartis.
-
Inhibitex has announced that the FDA has granted Aurexis, its humanized monoclonal antibody, fast track designation.
-
-
With the flu vaccine supply cut almost in half this season, health care providers and officials are turning to antivirals to fill in the gap. No one knows, however, if the four antiviral medications amantadine (Symmetrel), rimantadine (Flumadine), zanamivir (Relenza), and oseltamivir (Tamiflu) can meet the demand either. Robert B. Couch, MD, once tried to find out from distributors about the amount of antiviral supply.
-
Part 2 of 2: Availability and Cost, Clinical Studies, Critique of Studies, Recommendations/Conclusion.
-
With the flu season upon us and only half the normal supply of vaccine available, ED managers are preparing and bracing for a greater influx of flu patients this year.
-
If the flu vaccine shortage leads to a significant surge in flu patients, maintaining optimal staff health will be critical to providing adequate care for those patients, observers agree.
